Cathay Biotech Inc. (SHA:688065)
China
· Delayed Price · Currency is CNY 46.55
-0.44 (-0.94%)
Apr 28, 2026, 3:00 PM CST
Cathay Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 3,295 | 2,819 | 2,067 | 2,332 | 2,296 | Upgrade
|
| Other Revenue | - | 138.84 | 47.17 | 108.67 | 67.67 | Upgrade
|
| Revenue | 3,295 | 2,958 | 2,114 | 2,441 | 2,363 | Upgrade
|
| Revenue Growth (YoY) | 11.40% | 39.91% | -13.39% | 3.28% | 57.86% | Upgrade
|
| Cost of Revenue | 2,168 | 2,121 | 1,535 | 1,612 | 1,526 | Upgrade
|
| Gross Profit | 1,127 | 836.44 | 579.23 | 829.2 | 837.21 | Upgrade
|
| Selling, General & Admin | 235 | 222 | 221.61 | 232.28 | 175.11 | Upgrade
|
| Research & Development | 237.89 | 233.34 | 189.13 | 187.71 | 133.53 | Upgrade
|
| Other Operating Expenses | -19.69 | 13.83 | 9.21 | -4.09 | 22.94 | Upgrade
|
| Operating Expenses | 453.2 | 472.51 | 413.68 | 422.59 | 337.95 | Upgrade
|
| Operating Income | 674.2 | 363.93 | 165.55 | 406.61 | 499.25 | Upgrade
|
| Interest Expense | - | -27.43 | -32.17 | -20.01 | -16.29 | Upgrade
|
| Interest & Investment Income | 1.4 | 160.75 | 219.77 | 236.78 | 229.61 | Upgrade
|
| Earnings From Equity Investments | - | -8.95 | -7.82 | -3.71 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 36.73 | 29.59 | 82.97 | -14.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 83.55 | -6.04 | -5.7 | -4.61 | -0.59 | Upgrade
|
| EBT Excluding Unusual Items | 759.16 | 518.99 | 369.22 | 698.03 | 697.84 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.71 | 0.42 | -0.01 | 0.07 | - | Upgrade
|
| Asset Writedown | -135.7 | -0.05 | -0.26 | -0.02 | -0.06 | Upgrade
|
| Other Unusual Items | - | 28.66 | 79.97 | -2.09 | 26.66 | Upgrade
|
| Pretax Income | 630.16 | 548.02 | 448.92 | 695.99 | 724.45 | Upgrade
|
| Income Tax Expense | 100.66 | 73.43 | 40.39 | 83.34 | 90.94 | Upgrade
|
| Earnings From Continuing Operations | 529.5 | 474.59 | 408.54 | 612.65 | 633.51 | Upgrade
|
| Minority Interest in Earnings | 31.22 | 14.37 | -42.01 | -59.39 | -38.79 | Upgrade
|
| Net Income | 560.72 | 488.96 | 366.52 | 553.27 | 594.72 | Upgrade
|
| Net Income to Common | 560.72 | 488.96 | 366.52 | 553.27 | 594.72 | Upgrade
|
| Net Income Growth | 14.68% | 33.41% | -33.75% | -6.97% | 29.94% | Upgrade
|
| Shares Outstanding (Basic) | 684 | 582 | 582 | 582 | 583 | Upgrade
|
| Shares Outstanding (Diluted) | 684 | 582 | 582 | 582 | 583 | Upgrade
|
| Shares Change (YoY) | 17.47% | 0.05% | -0.10% | -0.11% | 7.38% | Upgrade
|
| EPS (Basic) | 0.82 | 0.84 | 0.63 | 0.95 | 1.02 | Upgrade
|
| EPS (Diluted) | 0.82 | 0.84 | 0.63 | 0.95 | 1.02 | Upgrade
|
| EPS Growth | -2.38% | 33.33% | -33.68% | -6.86% | 21.01% | Upgrade
|
| Free Cash Flow | -339.34 | -22.38 | -1,000 | -3,395 | -880.49 | Upgrade
|
| Free Cash Flow Per Share | -0.50 | -0.04 | -1.72 | -5.83 | -1.51 | Upgrade
|
| Dividend Per Share | - | 0.400 | 0.190 | 0.180 | 0.321 | Upgrade
|
| Dividend Growth | - | 110.53% | 5.56% | -43.99% | -43.75% | Upgrade
|
| Gross Margin | 34.22% | 28.28% | 27.40% | 33.97% | 35.42% | Upgrade
|
| Operating Margin | 20.46% | 12.30% | 7.83% | 16.66% | 21.12% | Upgrade
|
| Profit Margin | 17.02% | 16.53% | 17.34% | 22.66% | 25.16% | Upgrade
|
| Free Cash Flow Margin | -10.30% | -0.76% | -47.32% | -139.06% | -37.25% | Upgrade
|
| EBITDA | 989.8 | 679.85 | 451.26 | 671.73 | 667.79 | Upgrade
|
| EBITDA Margin | 30.04% | 22.98% | 21.34% | 27.52% | 28.25% | Upgrade
|
| D&A For EBITDA | 315.59 | 315.92 | 285.72 | 265.12 | 168.54 | Upgrade
|
| EBIT | 674.2 | 363.93 | 165.55 | 406.61 | 499.25 | Upgrade
|
| EBIT Margin | 20.46% | 12.30% | 7.83% | 16.66% | 21.12% | Upgrade
|
| Effective Tax Rate | 15.97% | 13.40% | 9.00% | 11.97% | 12.55% | Upgrade
|
| Revenue as Reported | - | 2,958 | 2,114 | 2,441 | 2,363 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.